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Abstract
Prostate cancer remains a significant public health concern among men in the U.S. and worldwide. Epidemiologic
studies have generally produced inconclusive results for dietary risk factors for prostate cancer, including
consumption of red and processed meats. We aimed to update a previous meta-analysis of prospective cohorts of
red and processed meats and prostate cancer with the inclusion of new and updated cohort studies, as well as
evaluate meat cooking methods, heme iron, and heterocyclic amine (HCA) intake exposure data. A comprehensive
literature search was performed and 26 publications from 19 different cohort studies were included. Random effects
models were used to calculate summary relative risk estimates (SRREs) for high vs. low exposure categories.
Additionally, meta-regression analyses and stratified intake analyses were conducted to evaluate dose-response
relationships. The SRREs for total prostate cancer and total red meat consumption, fresh red meat consumption,
and processed meat consumption were 1.02 (95 % CI: 0.92–1.12), 1.06 (95 % CI: 0.97–1.16), and 1.05 (95 % CI:
1.01–1.10), respectively. Analyses were also conducted for the outcomes of non-advanced, advanced, and fatal
prostate cancer when sufficient data were available, but these analyses did not produce significant results. No
significant SRREs were observed for any of the meat cooking methods, HCA, or heme iron analyses. Dose-response
analyses did not reveal significant patterns of associations between red or processed meat and prostate cancer. In
conclusion, the results from our analyses do not support an association between red meat or processed consumption
and prostate cancer, although we observed a weak positive summary estimate for processed meats.
Keywords: Prostate cancer, Red meat, Processed meat, Meta-analysis, Review, Epidemiology, Cooking methods,
Heterocyclic amines, Diet
Introduction
Prostate cancer is the second most common cancer in
men worldwide, with an estimated 1.1 million incident
cases and 0.3 million deaths occurring in 2012, according
to the World Health Organization (WHO) Cancer Report
2014 [1]. Prostate cancer is more commonly diagnosed in
high-resource countries, which is likely attributable to
higher age attainment and the availability and prevalence
of prostate-specific antigen (PSA) testing. Incidence rates
in these countries have generally leveled off in the past
two decades, but continue to increase in low and middle
resource countries [2]. In the United States (U.S.), an
estimated 220,800 new cases and 27,540 deaths due to
prostate cancer will occur in 2015 [3]. Prostate cancer
comprises 13.3 % of all new cancer cases and 4.7 % of
cancer deaths in the U.S. The National Cancer Institute
has published that approximately 14.0 % of men in the
U.S. will be diagnosed with prostate cancer at some point
during their lifetime, although the number of incident
cases has decreased by an average of 4.3 % each year from
2002 to 2012 [3].
Major identified risk factors for prostate cancer of
clinical significance include increasing age, family history
of this malignancy, and African-American race [1].
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Epidemiologic studies have demonstrated that the dis-
parity in incidence and mortality rates observed in low
resource countries tends to disappear after migration to
a high resource country, suggesting that lifestyle factors
may influence the risk of prostate cancer [4, 5]. Many
dietary factors have been evaluated for prostate cancer
risk, including consumption of dairy products, alcohol,
vitamin E, animal fat, and lycopene, with generally incon-
clusive results [6]. Specifically, several epidemiologic stud-
ies have assessed the relationship between consumption of
red and processed meats and risk of prostate cancer. In
their 2014 review of prostate cancer risk factors, the
World Cancer Research Fund/American Institute for
Cancer Research (WCRF/AICR) found the available epide-
miologic and mechanistic data for red and processed
meats and prostate cancer to be limited and insufficient to
make a conclusion in relation to prostate cancer risk [7].
A postulated hypothesis for a potential association
between meat consumption and prostate cancer is the
presence of heterocyclic amines (HCA) that are formed
in cooked meats, particularly meats cooked at high tem-
peratures or to a “well-done” degree [8–10]. Other com-
pounds suspected to be associated with increased cancer
risk are polycyclic aromatic hydrocarbons (PAH), par-
ticularly benzo(a)pyrene (B(a)P), also formed by meats
cooked over flame or at high temperature, and heme
iron, a compound found predominantly in red meat but
also found in poultry and fish [10, 11]. However, asses-
sing exposures such as HCA or heme iron in epidemio-
logic studies is not a straightforward process as these are
factors not ascertained via food frequency question-
naires, and thus, are evaluated as secondary exposures.
We published a meta-analysis in 2010 of 15 prospect-
ive studies of red and processed meat intake and pros-
tate cancer and observed no association for red meat
consumption and a weakly elevated summary association
between processed meat intake and prostate cancer [12].
As updated cohorts and new studies have since been
published [13–19], the state of the epidemiologic science
was updated in the current review and meta-analysis.
Thus, our specific objectives were as follows: (i) calculate
summary relative risk estimates for red and processed
meat intake and prostate cancer, (ii) conduct subgroup
analyses for red and processed meats and advanced,
non-advanced, and lethal prostate malignancy, (iii) con-
duct dose-response and meta-regression analyses, (iv)
identify sources of heterogeneity through sub-group and
sensitivity analyses, and (v) assess the potential for publi-
cation bias in the literature for red and processed meat
and prostate cancer. Furthermore, to our knowledge, no
meta-analysis has been published on prospective studies
that assessed exposure to HCAs, PAHs from cooking,
heme iron, or data on meat cooking methods and risk of
prostate cancer. Therefore, additional objectives for this
meta-analysis were to estimate summary relative risk es-
timates for these compounds and risk of prostate cancer.
Review
We followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines for
this systematic review and meta-analysis [20]. The
PRISMA checklist was included as part of the submission
process. The 27 checklist items pertain to the content of a
systematic review and meta-analysis, which includes the
title, abstract, methods, results, discussion, and funding. A
diagram of the search strategy is shown in Fig. 1.
Literature search and study identification
Literature searches were conducted to identify relevant
articles in the PubMed and EMBASE databases through
September, 2015 with no lower date limit. The exposures
of interest included fresh red meat (generally defined as
beef, pork, or lamb, e.g. steak, pork chops, etc.), proc-
essed meat (typically defined as beef, pork, or lamb that
has undergone methods of preservation, including smok-
ing, curing, or drying, e.g. bacon, hot dogs, etc.; some
studies may have included processed poultry, e.g., deli
meats, turkey hot dogs, etc.), and total red meat (a com-
bination of fresh red meat and processed meat) [21, 22].
Additional exposures of interest included various methods
of cooking or consuming meat (grilled, fried, broiled, well-
done, rare), heterocyclic amines (DiMeIQx, MeIQx, PhIP,
total mutagenic activity), B(a)P, and heme iron. We did
not include data on poultry or fish, apart from their pos-
sible inclusion in the processed meat variables. The out-
comes of interest included total prostate cancer, non-
advanced prostate cancer (Stage I/II), advanced prostate
cancer (Stage III/IV), and fatal prostate cancer. The follow-
ing terms were used in the search string: “prostate can-
cer”[Title/Abstract] AND (“meat”[Title/Abstract] OR
“foods”[Title/Abstract] OR “food habits”[Title/Abstract]
OR “feeding behavior”[Title/Abstract] OR “food preferen-
ces”[Title/Abstract] OR “red meat”[Title/Abstract] OR
“minced meat”[Title/Abstract] OR “ham”[Title/Abstract]
OR “bacon”[Title/Abstract] OR “sausage”[Title/Abstract]
OR “processed meat”[Title/Abstract]) OR (“heterocyclic
amines”[Title/Abstract] OR “polycyclic aromatic hydrocar-
bons”[Title/Abstract] OR “heme iron”[Title/Abstract] OR
“cooked meat”[Title/Abstract] OR “cooking methods”[Ti-
tle/Abstract] OR “grilled meat”[Title/Abstract] OR
“charred meat”[Title/Abstract]). Additionally, the bibliog-
raphies of relevant meta-analyses and reviews were hand
searched to capture studies not identified through our elec-
tronic searches.
We excluded case–control studies from this analysis
because of the abundance of available prospective cohort
studies and the documented issues that accompany nu-
tritional assessments in case–control studies of diet and
Bylsma and Alexander Nutrition Journal  (2015) 14:125 Page 2 of 18
cancer [23]. We also excluded studies of dietary patterns
unless the authors analyzed an exposure for red or
processed meat independently of a dietary pattern. In
addition, cross-sectional surveys, ecologic analyses, case
reports, editorials, and experimental animal studies
were excluded. If multiple articles were identified that
analyzed data within the same cohort, analyses pre-
sented from different studies that utilized unique expo-
sures or outcomes (e.g. one study reporting fatal
prostate cancer cases only and another study reporting
total prostate cancer) were included in the meta-
analysis. For example, in a sensitivity analysis by race,
we used data from Major et al. 2011 (NIH-AARP co-
hort) for African-American men, although data from
the full cohort (Sinha et al. 2009) was used for overall
analyses. If no differences in analyses were noted be-
tween published studies of the same cohort, the deci-
sion of which data to include was made using these
criteria: (i) size of the cohort, (ii) number of years of
follow-up, and (iii) number of confounders adjusted for
in multivariate models.
Data extraction and statistical analysis
The following data were extracted from each study: au-
thor, year of publication, cohort name, description of
cohort, size of analytic cohort, years of follow-up, race,
outcome, number of incident cases, year diet was assessed,
diet assessment method, meat/cooking method/HCA
definition and items included in definition, exposure cat-
egory, exposure category definition and units, RR, 95 %
Confidence Interval (CI), p-value for trend, and statistical
adjustments. If both crude and adjusted RRs were pre-
sented within a study, the most fully adjusted RR was
abstracted.
Random effects models were used to calculate sum-
mary relative risk estimates (SRRE), 95 % CIs, p-values
for heterogeneity, and I2 values. This model creates
study weights that are equal to the inverse of the vari-
ance of each study’s effect estimate according to the
methodology propounded by DerSimonian and Laird
[24]. Relative risks comparing the highest unit of con-
sumption against the lowest unit of consumption within
each study were combined across all studies to produce
Fig. 1 PRISMA diagram. Systematic search for eligible studies of red and processed meat consumption and prostate cancer
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a summary association. Fixed effects models were used
to combine mutually-exclusive results within individual
studies if no composite variable for total red meat, fresh
red meat, or processed meat was provided (e.g. combin-
ing results for bacon, sausage, and salami into one meas-
ure of “processed meat”), so that one estimate for each
meat category was included in each model. Primary
meta-analysis models were created for the exposures of
total red meat, fresh red meat, and processed red meat,
and for the outcomes of total prostate cancer, non-
advanced prostate cancer, advanced prostate cancer, and
fatal prostate cancer, if sufficient data (≥2 studies) were
available. Secondary meta-analysis models were gener-
ated to evaluate the exposures of various cooking
methods, HCA, B(a)P, and heme iron. Sub-group and
sensitivity analyses were performed to evaluate potential
patterns of associations and sources of heterogeneity by
descriptive study factors such as race, geographic region,
and number of cases. Sensitivity analyses removing one
study at a time were conducted to determine the effect
of each study on the model.
As the units of consumption varied across studies, we
harmonized the data into “servings per day” based on
U.S. Department of Agriculture reference amounts cus-
tomarily consumed per eating occasion: 85 grams per
one serving of total red meat, 75 grams per serving of
fresh red meat, and 50 grams per serving of processed
red meat [25]. Studies that provided intake categories of
grams per 1000 kcal were doubled to estimate intake for
a typical 2000 kcal diet. We assessed dose-response rela-
tionships between red and processed meat and prostate
cancer using two different methods: linear regression
modelling and categorical analyses. We first conducted
meta-regression analyses to estimate the risk of prostate
cancer per each incremental serving of red or processed
meat intake. To do this, we included all risk estimates
and 95 % confidence intervals for each intake category
reported in the individual studies. As a complimentary
dose-response analysis, we performed meta-analyses
based on stratified intake categories utilizing relative
risks from every reported intake category. Thus, we were
able to incorporate all reported intake stratifications at
the individual study level, and the meta-analytic intake
groups were created after visualizing the distribution of
the exposure data across all studies. However, this
method is restricted to only those studies that report
quantitative intake metrics, thereby excluding studies
that report RRs for unspecified levels of intake, such as
low, medium, or high, or undefined quantiles of intake.
The percentage of variance due to between-study het-
erogeneity was estimated using the Cochran’s Q test and
I2 statistic [26]. Publication bias was evaluated visually
by creating funnel plots, as well as by conducting Egger’s
regression tests and using the Duval and Tweedie
imputation method [27]. Forest plots were generated
for total red meat consumption and total prostate
cancer, processed meat and total prostate cancer, and
HCA intake and total prostate cancer. All analyses
were done using Comprehensive Meta-Analysis Soft-
ware (version 3.3.070; Biostat, Englewood, New Jersey,
USA).
Results
We identified 26 prospective cohort studies of red and
processed meat consumption and prostate cancer from
19 different cohorts. Descriptive study characteristics of
prospective cohort studies of red and processed meat
consumption and prostate cancer risk are presented in
Table 1 [13–15, 19, 28–45]. The majority of the cohorts
(fourteen) were conducted in the United States, one in
Canada, one in Japan, and three were conducted in Eur-
ope. Over 700,000 male participants were evaluated in
this meta-analysis. The duration of follow-up ranged
from 6 to 22 years. Although several studies were not
performed in the United States, the amount of red and
processed meat consumed was generally comparable to
levels consumed in the U.S. diet, according to the USDA
[46]. Table 2 presents the results of the meta-analyses
for prostate cancer and intake of total red meat, fresh
red meat, and processed meat.
Total red meat
Ten prospective cohort studies were included in the
meta-analysis of total red meat and total prostate cancer
[13, 14, 34,36, 40, 41, 44, 45, 47–48]. Red meat was typ-
ically either undefined or defined as a combination of
processed and unprocessed beef, pork, and lamb. No as-
sociation between total red meat intake and total pros-
tate cancer was observed (SRRE = 1.02; 95 % CI: 0.92–
1.12), although there was significant heterogeneity be-
tween studies (Fig. 2). A sensitivity analysis was per-
formed without the study by Veierod et al. in 1997, as the
estimate was a high outlier and adjusted for very few con-
founding factors as compared to the other studies (age at
study inclusion and attained age were the only evaluated
confounding factors). The SRRE did not appreciably
change with the removal of this study. No dose-response
relationship was evident in meta-regression analyses or
categorical intake analyses, which is overall not supportive
of a positive trend. Meta-analyses were also conducted for
total red meat and risk of advanced, non-advanced, and
fatal prostate cancer. No significant associations were ob-
served in these analyses, nor was there significant hetero-
geneity present between studies. Additionally, subgroup
analyses based on geographic location, number of partici-
pants, and duration of follow-up time were conducted and
no effect modification by these factors was demonstrated.
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Table 1 Characteristics of prospective cohort studies of red and processed meat and prostate cancer a

















1864 (661) 69.3 (10.5) [mean (SD)
controls]; 66.2 (8.4) [mean
(SD) cases]
1995–1998 8 Red meat All PCa; nonadvanced
PCa; advanced PCa





Life Span Study Cohort
(Japan)
18,119 (196) 51–89 1979–1980 16.9
[mean]
Pork All PCa Age, calendar period, city
of residence, radiation





52 [median] 1989–2004 18 Red meat; processed meat All PCa Study center, education,
marital status, height,





55–74 1993–2001 11 Red meat; processed meat Total PCa; incident PCa;
advanced PCa
Age, race, study center,
fam hx, history of diabetes,
number of screening exams
during follow-up, smoking
status, physical activity,
aspirin use, BMI, and intake of
total energy, supplemental
vitamin E, and lycopene
Gann et al,
1994 [32]
PHS (US) 240 (120) 40–84 1982 6 Beef, pork, or lamb as
a main dish
All PCa None reported
Hsing et al,
1990 [33]
LBC (US) 17,633 (149) ≥35 1966 20 Red meat (processed and
unprocessed)
Fatal PCa Age, tobacco use
Koutros et
al, 2008 [34]
AHS (US) 23,080 (668) 48.3 [mean] 1993–1997 10 Red meat; pork chops/ham
steaks; beef steaks; hamburgers;
bacon/sausage
Total PCa; incident PCa;
advanced PCa
Age, state of residence, race,








8881 (198) ≥18 1975–1980 14 Pork; beef Total PCa; localized stage
PCa; regional and distant
stage PCa
Age, ethnicity, and income
Major et al,
2011 [19]
NIH-AARP (US) 7949 (1089)
(Blacks only)
50–71 1995–1996 11 Red meat; processed meat Total PCa;
Advanced PCa
Age, education, marital status,
fam hx, hx of diabetes, smoking,






40–75 1986 10 Red meat; beef, pork, lamb
(main dish); beef, pork, lamb



























14,000 (180) ≥25 1976 6 Beef hamburger; beef steak;





CAROT (US) 12,000 (890) 50–69 1989 11
[mean]
Red meat Total PCa;
aggressive PCa;
nonaggressive PCa
Age, energy intake, BMI, smoking,












Time on study, ethnicity, family
history of prostate cancer,
education, BMI, smoking
status and energy intake
Richman et
al, 2011 [15]
HPFS (US) 27,607 (199) 40–75 1986 22 Total red meat (processed and
unprocessed); unprocessed red
meat; processed red meat










50–74 1992 9 Total red meat (processed and
unprocessed); unprocessed
red meat;
All PCa; metastatic PCa Age at entry, total calorie
intake, BMI, level of education,
fam hx, history of PSA testing,












Age, energy intake, consumption
of tomato products, BMI





NLCS (Netherlands) 2167 (642) 55–69 1986 6.3 Beef; pork; minced meat

























testing in the past 3 years,
hx of diabetes, BMI,
smoking history, frequency
of vigorous physical activity,
and intakes of alcohol,
calcium, tomatoes,
alpha-linolenic acid,






25,708 (72) 16–56 1977–1983 15 Main meals with hamburgers,
meatballs, etc.



















50–69 1985–1988 21 Red meat; beef; sausages All PCa; advanced
PCa
Age, energy intake, smoking
dose and duration, trial
intervention assignment,






40–75 1986 14 Total red meat, processed
meat
Advanced PCa Age, height, smoking, family
history of prostate cancer,
race, history of vasectomy,
vigorous exercise, body
mass index, alcohol
intake, and total energy
intake
a PCa, prostate cancer; BMI, body mass index; fam hx, family history; ATBC, Alpha-Tocopherol Beta-Carotene Cancer Prevention Study; EPIC, European Prospective Investigation into Cancer and Nutrition; PLCO, Prostate,
Lung, Colorectal, Ovarian Screening Trial; PHS, Physicians’ Health Study; LBC, Lutheran Brotherhood Cohort; AHS, Agricultural Health Study; NIH-AARP, National Institutes of Health-American Association for Retired













Table 2 Summary relative risk estimates (SRRE), 95 % confidence intervals (CI), p-values for heterogeneity and I2 statistics for red and
processed meat intake and prostate cancer (high vs. low exposure unless otherwise noted)
Model (number of studies a or data points†) SRRE 95 % CI P-value for Heterogeneity; I2
Total red meat
Total red meat and total prostate cancer (n = 10) 1.02 0.92–1.12 0.006; 61.0 %
Per 1 serving/day increase 0.96 0.91–1.00
Intake of 0–0.50 servings/day (n = 5) 1.41 1.09–1.81 0.189; 34.85 %
Intake of >0.50–1.0 servings/day (n = 13) 1.02 0.98–1.05 0.735; 0.00 %
Intake of >1.0–1.5 servings/day (n = 10) 1.01 0.93–1.10 0.077; 42.07 %
Intake of >1.0 servings/day (n = 7) 0.88 0.75–1.04 0.005; 67.68 %
Total red meat and non-advanced prostate cancer (n = 3) 0.98 0.63–1.53 0.051; 66.3 %
Per 1 serving/day increase 0.71 0.46–1.10
Intake of <1 serving/day (n = 4) 1.10 0.92–1.31 0.619; 0.00 %
Intake of >1 serving/day (n = 5) 0.89 0.66–1.19 0.060; 55.69 %
Total red meat and advanced prostate cancer (n = 9) 1.01 0.86–1.17 0.177; 30.2 %
Per 1 serving/day increase 0.97 0.91–1.04
Intake of 0–0.75 servings/day (n = 9) 1.08 0.94–1.23 0.319; 13.78 %
Intake of >0.75–1.0 servings/day (n = 4) 1.06 0.92–1.23 0.697; 0.00 %
Intake of >1.0–1.5 servings/day (n = 8) 1.04 0.92–1.18 0.481; 0.00 %
Intake of >1.0 servings/day (n = 4) 1.14 0.95–1.37 0.328; 12.95 %
Total red meat and fatal prostate cancer (n = 3) 1.06 0.82–1.37 0.35; 4.80 %
Per 1 serving/day increase 1.05 0.73–1.52
Intake of <1 serving/day (n = 5) 1.09 0.91–1.30 0.350; 9.89 %
Intake of >1 serving/day (n = 5) 1.15 0.96–1.38 0.474; 0.00 %
Fresh red meat
Fresh red meat and total prostate cancer (n = 9) 1.06 0.97–1.16 0.113; 38.3 %
Per 1 serving/day increase 0.91 0.81–1.03
Intake of 0- < 0.25 servings/day (n = 9) 1.08 0.97–1.19 0.924; 0.00 %
Intake of 0.25- < 0.5 servings/day (n = 8) 1.07 1.02–1.13 0.519; 0.00 %
Intake of 0.5–0.75 servings/day (n = 6) 1.04 0.97–1.12 0.363; 8.28 %
Intake of >0.75 servings/day (n = 9) 1.07 0.95–1.19 0.171; 30.95 %
Fresh red meat and advanced prostate cancer (n = 6) 1.01 0.86–1.20 0.180; 34.107 %
Per 1 serving/day increase 0.88 0.69–1.12
Intake of 0–0.25 servings/day (n = 9) 1.14 0.97–1.34 0.776; 0.00 %
Intake of >0.25–0.50 servings/day (n = 8) 0.99 0.89–1.10 0.543; 0.00 %
Intake of >0.50 servings/day (n = 10) 0.99 0.89–1.11 0.398; 4.66 %
Processed meat
Processed red meat and total prostate cancer (n = 11) 1.05 1.01–1.10 0.406; 3.38 %
Per 1 serving/day increase 1.01 0.96–1.05
Intake of 0–0.25 servings/day (n = 9) 1.05 0.99–1.10 0.369; 7.93 %
Intake of >0.25–0.50 servings/day (n = 12) 1.05 1.00–1.09 0.407; 3.91 %
Intake of >0.50–0.75 servings/day (n = 6) 1.02 0.97–1.07 0.506; 0.00 %
Intake of >0.75 servings/day (n = 10) 1.04 0.99–1.10 0.176; 29.20 %
Processed meat and advanced prostate cancer (n = 8) 1.12 0.95–1.33 0.040; 52.4 %
Per 1 serving/day increase 1.10 0.98–1.24
Intake of 0–0.25 servings/day (n = 12) 0.95 0.80–1.12 0.004; 60.09 %
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Fresh red meat
Nine cohort studies evaluated the association between
fresh red meat and total prostate cancer and were in-
cluded in the meta-analysis [14, 29, 32, 34, 35, 37, 39–41].
Fresh red meat was typically defined as fresh or unpro-
cessed beef, veal, lamb, and pork. Fresh red meat was not
significantly associated with prostate cancer (SRRE = 1.06;
95 % CI: 0.97–1.16), and the model was relatively homo-
geneous. A sensitivity analysis was conducted after the
removal of Gann et al. 1994, an outlier estimate, and Mills
et al. 1989, a study in which the only confounding factor
adjusted for was age. The SRRE did not appreciably
change after either of these studies were removed from
the analysis. Sufficient data were available to stratify ana-
lyses by race; however, no significant associations were
observed for White, Black, or Asian participants. In dose-
response analyses, no significant risk was observed with a
one-serving increase of fresh red meat, nor was there evi-
dence of a trend in the stratified intake analyses, although
a significant association was observed in the second
stratum (0.25 to <0.50 servings per day). Again, this was
likely an artifact due to multiple comparisons. A meta-
analysis was also conducted for fresh red meat and
advanced prostate cancer but no association was observed.
In subgroup analyses, no remarkable patterns of associa-
tions were observed by duration of follow-up time or geo-
graphic region. However, when analyses were stratified by
number of cases, the model including studies with <1000
cases had a statistically significant SRRE (1.23, 95 % CI:
1.07–1.41), while the model for studies with >1000 cases
was null (SRRE = 0.99, 95 % CI: 0.93–1.05), which may
have been due to selective reporting among smaller stud-
ies. Despite this, the epidemiologic evidence does not sup-
port an independent association between intake of fresh
red meat and risk of prostate cancer.
Processed meat
Eleven prospective cohort studies were included in the
meta-analysis of processed meat and total prostate can-
cer [14, 30, 34, 35, 39–44, 47]. Processed meat was gen-
erally either defined as cured or salted meats, including
ham, hot dogs, cold cuts, sausage, and bacon, or un-
defined. The result of the meta-analysis was a weakly
elevated-significant summary risk estimate of 1.05 (95 %
CI: 1.01–1.10) with no evidence of statistical heterogen-
eity between studies (Fig. 3). Analyses stratified by race
showed no significant associations for White, Black, or
Asian participants. In the meta-regression analysis, no
Table 2 Summary relative risk estimates (SRRE), 95 % confidence intervals (CI), p-values for heterogeneity and I2 statistics for red and
processed meat intake and prostate cancer (high vs. low exposure unless otherwise noted) (Continued)
Intake of >0.25–0.50 servings/day (n = 9) 1.07 0.90–1.26 0.009; 60.61 %
Intake of >0.50 servings/day (n = 8) 1.13 0.99–1.29 0.116; 39.42 %
Processed meat and fatal prostate cancer (n = 2) 1.09 0.63–1.90 0.073; 68.9 %
Per 1 serving/day increase 0.84 0.44–1.61
Intake of <0.50 servings/day (n = 4) 0.93 0.75–1.15 0.276; 22.49 %
Intake of >0.50 servings/day (n = 3) 0.95 0.69–1.30 0.112; 54.36 %
a Number of studies indicated in parentheses for high vs. low analyses; †number of data points indicated in parentheses for dose- response analyses (in italics)
Fig. 2 Meta analysis of total red meat and total prostate cancer
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evidence of a dose-response relationship was observed for
incremental intake levels of processed meat. None of the
stratified intake analyses produced significant associations
for different categories of intake of processed meats. Suffi-
cient data were available to perform analyses for advanced
and fatal prostate cancer as well; however, no significant
associations were observed in these analyses. Subgroup
analyses revealed that the overall SRRE may be driven by
studies conducted in the U.S. (SRRE for U.S. studies only:
1.05, 95 % CI: 1.01–1.10). Despite this, interpretation of
findings for processed meat intake and prostate cancer
should be tempered because of the summary association
near the null value, the variability in processed meat defini-
tions across studies, the different types of additives used in
processed meat production, and the colinearity between
processed meat intake and other dietary and lifestyle fac-
tors that may influence risk.
Cooking methods and heterocyclic amines
Characteristics of prospective cohort studies of various
meat cooking methods, heterocyclic amines, heme iron
intake and prostate cancer are shown in Table 3 [16, 18,
34, 44, 47, 49, 50]. The results for these meta-analyses
are shown in Table 4.
Five prospective cohort studies provided estimates
for various meat cooking methods and consumption
preferences associated with total and advanced pros-
tate cancer [16, 18, 34, 44, 47]. Though the methods
of cooking meat varied between studies, the exposure
variables were categorized into five groups: broiled
meats, grilled or barbequed meats, pan-fried meats,
rare/medium cooked meats, and well-done/very well-
done meats. All of the summary associations included the
null value of 1.00 in the confidence interval. In the meta-
analyses for advanced prostate cancer, no significant asso-
ciations were observed.
The prospective cohort studies that provided results
for cooking methods and total and advanced prostate
cancer also provided estimates for various heterocyclic
amines [16, 18, 34, 44, 47]. Additionally, Rohrmann et al.
recently published an update of HCA consumption and
prostate cancer in the Health Professionals Follow-Up
Study (HPFS) cohort [49]. The heterocyclic amines eval-
uated included B(a)P, DiMeIQx, MeIQx, PhIP, and total
mutagenic activity. No statistically significantly increased
risks for total prostate cancer were observed for any
heterocyclic amine (Fig. 4). The SRRE for total muta-
genic activity was 1.09 (95 % CI: 1.00–1.20), mainly
driven by results from the HPFS study. Similarly, in the
meta-analyses for advanced prostate cancer, no signifi-
cant associations were observed. The HPFS study in-
cluded two estimates for PhIP intake: total PhIP and
PhIP from red meat only. Because the other cohort stud-
ies used a total PhIP estimate in their analyses, we uti-
lized that estimate from Rohrmann et al. 2015 and
performed a sensitivity analysis including the PhIP esti-
mate from red meat alone. The sensitivity analysis did
not meaningfully change the SRRE from the original re-
sults. We elected not to perform dose-response analyses
for cooking methods or HCA intake as no significant
SRREs were observed for the high vs. low analyses, and
because of the fact that HCAs are secondary exposures.
Heme iron
Two studies were identified that included data on heme
iron consumption and prostate cancer [44, 50]. No asso-
ciation was found for total prostate cancer (SRRE = 1.00,
95 % CI: 0.84–1.19; p-het = 0.006), and a non-statistically
significant association was observed for advanced pros-
tate cancer (SRRE = 1.06, 95 % CI: 0.73–1.55; p-het =
0.018) with statistically significant heterogeneity in both
models.
Fig. 3 Meta analysis of processed meat and total prostate cancer
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Table 3 Characteristics of prospective cohort studies of meat cooking methods, heterocyclic amines, and/or heme iron and prostate cancer a

















PLCO (US) 29,361 (1338) 55–74 1993–2001 11 Barbequed meat; panfried
meat; very well-done meat
DiMeIQx; MeIQx; PhIP;
B(a)P; Mutagenic activity








AHS (US) 23,080 (668) 48.3 [mean] 1993–1997 10 Grilled meat; pan-fried meat;
broiled meat; rare or medium
cooked meat; well and very
well done cooked meat
DiMeIQx; MeIQx; PhIP;
B(a)P; Mutagenic activity




HPFS (US) 26,030 (2770) 40–75 1996 14 None MeIQx; DiMeIQx; PhIP;
Meat-Derived Mutagenicity
Index






9578 (337) 40–65 2002–2004 7 Degree of browning: strong/
extreme; light/moderate





4169 (2106) 45–75 1993–1996 8 Meat preference: medium;
well done
None Total PCa
Sinha et al, 2009
[44]
NIH-AARP (US) 175,343 (10,313) 50–71 1995–1996 8 Grilled/barbequed meat; pan-fried
meat; broiled meat; microwaved




Total PCa; advanced PCa;
fatal PCa
a PCa, prostate cancer; PLCO, Prostate, Lung, Colorectal, Ovarian Screening Trial; AHS, Agricultural Health Study; EPIC, European Prospective Investigation into Cancer and Nutrition; NIH-AARP, National Institutes of
Health-American Association for Retired Persons Diet and Health Study; HFPS, Health Professionals Follow-Up Study; DiMeIQx, 2- amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline; MeIQx, 2-amino-3,8-dimethylimidazo[4,5-














A visual assessment of the funnel plot for prospective
studies of total red meat intake and total prostate cancer
indicated the presence of slight publication bias (Fig. 5).
However, Egger’s regression test was not statistically sig-
nificant (p = 0.963) for this model. No statistical or visual
evidence of publication bias was observed for studies of
processed meat intake and total prostate cancer (Egger’s
regression method p = 0.211). Of note, although mar-
ginal visual evidence of publication bias was noted for
studies of fresh red meat and total prostate cancer,
Egger’s regression test was statistically significant (p =
0.001) (Fig. 6). Duval and Tweedie’s trim and fill method
was used to impute four studies to the left of the mean,
resulting in an adjusted SRRE of 1.004 (95 % CI: 0.91–
1.11). This SRRE was not meaningfully changed from
the original SRRE of 1.06 (95 % CI: 0.97–1.16), as the
confidence intervals were widely overlapped.
Discussion
Red and processed meats have been long-debated as po-
tential risk factors for prostate cancer. In this meta-
analysis, we evaluated the association between meat and
prostate cancer by quantitatively combining results from
prospective cohort studies of prostate cancer and red
meat, processed meat, meat cooking methods, HCA,
and heme iron. In high vs. low intake analyses as well as
dose-response models, we observed generally null results
for the association between red and processed meat and
prostate cancer.
The results from these analyses closely resemble the
results from our prior meta-analysis published in 2010,
Table 4 Summary relative risk estimates (SRRE), 95 % CI, p-values for heterogeneity and I2 values for cooking methods and HCA and
prostate cancer (high vs. low exposure)
Model (number of studies) SRRE 95 % CI P-value for Heterogeneity; I2
Cooking methods
Total Prostate Cancer:
Grilled/Barbequed meats (n = 3) 1.06 0.94–1.20 0.171; 45.5 %
Pan-fried meats (n = 3) 1.00 0.96–1.05 0.763; 0.00 %
Broiled meats (n = 2) 1.04 1.00–1.09 0.451; 0.00 %
Well-done/Very well done meats (n = 5) 1.09 0.95–1.26 0.062; 55.4 %
Rare/Medium meats (n = 4) 1.01 0.91–1.12 0.245; 27.9 %
Advanced Prostate Cancer:
Grilled/Barbequed meats (n = 3) 1.19 0.94–1.51 0.181; 41.5 %
Pan-fried meats (n = 3) 0.97 0.77–1.22 0.140; 49.2 %
Broiled meats (n = 2) 1.00 0.87–1.14 0.830; 0.00 %
Well-done/Very well done meats (n = 4) 1.24 0.90–1.71 0.075; 56.5 %
Rare/Medium meats (n = 3) 1.09 0.88–1.34 0.331; 9.57 %
Heterocyclic amines
Total Prostate Cancer:
DiMeIQx (n = 5) 1.03 0.97–1.09 0.530; 0.00 %
MeIQx (n = 5) 1.06 0.96–1.16 0.198; 33.5 %
PhIP (n = 5) 1.05 0.96–1.14 0.211; 31.6 %
Sensitivity analysis including “PhIP from red meat from Rohrmann 2015” 1.07 0.96–1.20 0.073; 53.4 %
B(a)P (n = 3) 1.01 0.90–1.14 0.169; 43.8 %
Mutagenic activity (n = 3) 1.09 1.00–1.20 0.725; 0.00 %
Advanced Prostate Cancer:
DiMeIQx (n = 5) 1.10 0.94–1.29 0.747; 0.00 %
MeIQx (n = 5) 0.93 0.78–1.11 0.931; 0.00 %
PhIP (n = 5) 0.97 0.83–1.14 0.668; 0.00 %
Sensitivity analysis including “PhIP from red meat from Rohrmann 2015” 1.05 0.86–1.30 0.192; 34.3 %
B(a)P (n = 3) 1.00 0.74–1.36 0.074; 61.9 %
Mutagenic activity (n = 3) 1.04 0.84–1.28 0.412; 0.00 %
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Fig. 4 Meta-analysis of heterocyclic amines and total prostate cancer
Fig. 5 Funnel plot of prospective studies of total red meat intake and total prostate cancer
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although no assessment of cooking methods, HCA, or
heme iron intake was undertaken in that publication
[12]. No significant association was observed for red or
processed meat and total or advanced prostate cancer in
our previous paper, although a weakly significant associ-
ation was found between a 30 g increment of processed
meat and total prostate cancer (SRRE: 1.02, 95 % CI:
1.00–1.04). After updating these analyses with newly-
published data from several well-established cohorts, the
nature of the scientific understanding of the relationship
between red and processed meat and prostate cancer
does not appear to have changed substantially. Thus, the
current analyses provide additional support to the notion
that red meat or processed meat consumption is not an
independent risk factor for prostate cancer. Of note, in
our previous publication, there was some evidence of
publication bias in the studies of processed meat intake
and prostate cancer, a finding that was not replicated in
the current analyses. The only difference between the
analyses was the addition of results from the Alpha-
Tocopherol, Beta-Carotene Cancer Prevention Study
[14] and updated results of the NIH-AARP Diet and
Health Study [44].
The presence of publication bias was observed in the
studies of fresh red meat consumption and total prostate
cancer. Given that the funnel plot appeared to be rela-
tively asymmetric, it may be presumed that studies of
fresh red meat and prostate cancer with negative results
have not been published or reported in the scientific lit-
erature. The Duval and Tweedie imputation method was
used to impute the results of four of these hypothetical
studies onto the funnel plot. This theoretical exercise is
used to estimate the results of a meta-analysis performed
using a more even distribution of study findings. How-
ever, in this case, the resulting SRRE for the meta-
analysis including the imputed hypothetical studies was
not significantly or meaningfully different than the ori-
ginal result. Subgroup analyses for this model demon-
strated that smaller studies (those with <1000 prostate
cancer cases) had higher risk estimates than larger stud-
ies, an observation that is represented visually in Fig. 6.
Despite the possibility of publication bias, the epidemio-
logic evidence that is currently available is not support-
ive of an association between intake of fresh red meat
and prostate cancer risk.
We did not observe any increased risk specifically for
advanced or lethal prostate cancer with consumption of
total red meat, fresh red meat, or processed meat, or any
cooking method, HCA, or heme iron. Some of the co-
hort studies included in our meta-analysis provided re-
sults by prostate cancer grade (high/low) [39, 49, 50].
However, these data were too sparse and heterogeneous
to combine analytically. Additional prospective cohort
data is necessary before any informed hypotheses can be
made regarding the intake of red and processed meat
and grade of prostate cancer.
Furthermore, we did not observe any overall evidence
of a dose-response relationship between red or proc-
essed meat and prostate cancer in meta-regression or
stratified intake analyses. However, our stratified intake
analyses were based on the inclusion of RRs reported in
the individual studies by each level of meat intake. For
Fig. 6 Funnel plot of prospective studies of fresh red meat intake and total prostate cancer
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example, of the ten studies that provided an RR for total
red meat consumption and total prostate cancer, only
three studies included intakes of <0.5 servings per day
(Veierod et al. 1997, Agalliu et al. 2011, and Koutros
et al. 2008), and five data points could be included from
these studies (three from Veierod et al. 1997, one from
Agalliu et al. 2011, and one from Koutros et al. 2008). Con-
sequently, the results from the stratified intake analyses
may be influenced by an over-representation of certain
studies at variable levels of intake, which is commonplace
in nutritional epidemiology. Thus, our two different dose-
response methods (i.e., linear and categorical) should serve
as complimentary analyses. Future studies with more
detailed quantitative intake metrics would facilitate a more
comprehensive dose-response analysis with greater statis-
tical precision and enhanced power in each intake stratum.
The 2015 HPFS update reported risk estimates for
prostate cancer and HCA intake stratified by consump-
tion of tomatoes, as lycopene is a hypothesized protect-
ive factor against prostate cancer [51, 52]. Participants
consuming tomato products at least twice per week were
found to have a generally decreased risk of prostate can-
cer when compared to those who consumed tomato
products less than two times per week for analyses of con-
sumption of most HCAs evaluated [49]. Although tomato
consumption may be correlated with other healthy life-
style factors, such as consumption of other fruits and
vegetables and physical activity, these results present a
novel and interesting method of viewing the data that may
be useful in other prospective cohort studies.
Multiple case–control studies have been published on
dietary risk factors, including red and processed meat
consumption, and prostate cancer. A case–control study
conducted in Uruguay found a significant trend with in-
creasing consumption of red meat, beef, and lamb, but no
increased risk or trend with processed meat consumption
[53]. A recent study in Pakistan found an increased risk of
prostate cancer with consumption of red meat (OR: 3.41;
95 % CI: 1.46–7.96) [54]. Results from the California
Collaborative Prostate Cancer Study showed no associ-
ation between both total red meat and processed meat
and localized and advanced prostate cancer. Modestly-
elevated significant associations were seen for advanced
prostate cancer and pan-fried red meat, red meat cooked
at high temperatures, and well-done red meat, but results
for grilled red meat, oven-broiled red meat, and baked red
meat were null [55]. A large case–control study in Cauca-
sian men in Washington State observed increased risks of
all prostate cancer, less aggressive cancer, and more ag-
gressive prostate cancer with the highest tertile of red
meat consumption [56]. Di Maso et al. analyzed data from
a network of case–control studies in Italy and Switzerland
and found no increased risk of prostate cancer with
medium and high consumption of red meat or by an
increase of 50 grams per day [57]. Collectively, associations
across case–control studies are largely inconsistent. Fur-
thermore, a very cautious and conservative interpretation
should be made when reviewing data from case–control
studies because of the well-known limitations of recall bias
and selective participation in such studies.
There are numerous challenges to evaluating second-
ary exposures such as heme iron and heterocyclic amines
in prospective cohort studies. First, virtually all epidemio-
logic studies included in this meta-analysis ascertained
dietary information through a food frequency question-
naire (FFQ). It is not possible to ascertain respondents’
usual exposure to dietary mutagens or heme iron or
heterocyclic amines from an FFQ. Thus, self-reported food
data are translated into secondary exposures using various
sources, such as the CHARRED database. The limitations
of using such data have been well-documented. Thus, re-
searchers are using self-reported dietary intake data (with
underlying biases), and applying this information to a data-
base that also has issues with exposure misclassification.
This is a major limitation in these types of epidemiologic
assessments. Second, many secondary exposures, such as
HCA, are not included in food composition databases,
since they are not a natural component of food and have
no nutritional value. Third, measurement is complicated
by reporting of consumption of mixed meat dishes or proc-
essed meats, whereby the specific level and type of meat is
difficult to estimate. Fourth, exposure to the same muta-
genic compounds reported in dietary studies may also re-
sult from tobacco smoke and other sources, as they may
be present in the environment and ambient air [58]. Fifth,
data from prospective studies is limited regarding other
methods of meat preparation, including marinades, which
have been suggested to decrease the potential for HCA
formation on the surface of meat due to their antioxidant
content [59, 60].
Despite these diverse limitations, we conducted meta-
analyses for prostate cancer risk and HCA intake given
the availability of data in prospective cohort studies and
because to our knowledge, no meta-analysis of meat
cooking methods or HCA consumption and prostate
cancer has previously been published. There was some
variation between studies in terms of variables used to as-
sess cooking methods; for example, the category of “well-
done/very well done meat” included the synonymous vari-
ables of “charred meat” and “degree of meat browning:
strong/extreme” found in other publications. Most of the
cohort studies that provided HCA data used the NCI
CHARRED database to estimate the amount of HCA con-
sumption in units of nanograms per day; however, if the
underlying data sources representing food intake vary be-
tween studies, estimates of HCA exposure levels may be
biased. In light of this, we combined measures of HCA ex-
posures across studies using meta-analysis methodology.
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These analyses produced no statistically significant sum-
mary associations for total or advanced prostate cancer
with high levels of exposure to PhIP, DiMeIQx, MeIQx, or
B(a)P. Although the association between total mutagenic
activity and total prostate cancer was 1.09, the estimate was
based on only three cohort studies. More results from
additional observational studies are needed before any de-
finitive conclusions can be made regarding these exposures.
The most prevalent HCA found in meats cooked at
high temperatures is PhIP [61, 62]. PhIP has been shown
to induce prostate tumors in rodent models [63–65].
Creton et al. found that PhIP exposures comparable to
dietary levels induced a rapid and transient increase in
phosphorylation of the mitogen-activated protein kinase
extracellular signal-related kinase pathway in the pros-
tate cancer cell line PC-3. When the pathway was inhib-
ited, migration of the PC-3 cells was significantly
reduced. As the stimulation of this pathway is associated
with the promotion and progression of neoplastic pro-
cesses, these results suggested that PhIP may be a tumor
initiator and promoter of prostate carcinogenesis [61].
Another mechanism was recently proposed by Glass-
Holmes et al., who suggested that PhIP may disrupt the an-
drogen receptor by binding to the ligand-binding domain
and competing with dihydrotestoerone in the native bind-
ing cavity of the receptor [66]. Although some epidemio-
logic studies have observed significant associations or
trends with PhIP consumption and prostate cancer
[47, 49], our summary association calculated from the
results of five well-established cohorts revealed null
associations for PhIP intake and total as well as ad-
vanced prostate cancer. Null results for PhIP and
prostate cancer risk have been corroborated in several
case–control studies [55, 67]. Further research is necessary
to determine why the results from epidemiologic studies
of PhIP consumption and prostate cancer contrast those
of mechanistic studies. As it stands, there is no compelling
epidemiologic evidence to support a relationship between
PhIP exposure and prostate cancer.
Additionally, mechanistic studies have implicated heme
iron as a potential prostate carcinogen as a catalyst of
oxidative reactions [11, 68]. We only identified two pro-
spective cohorts that evaluated the association between
heme iron consumption and prostate cancer. Heme iron
was found to be associated with an increased risk of total
prostate cancer and advanced prostate cancer in the NIH-
AARP cohort, but not with fatal prostate cancer [44].
However, the EPIC cohort did not observe any risk for
prostate cancer by stage or grade with heme iron con-
sumption [50]. Thus, the findings from these cohorts were
statistically heterogeneous. Because our findings do not
support an association between red meat intake and pros-
tate cancer, it is unlikely that heme iron is associated with
increasing the risk of this malignancy.
Conclusions
The results of our comprehensive meta-analysis show
that red meat or processed meat consumption is not asso-
ciated with increasing the risk of prostate cancer. A very
weak, albeit statistically significant, summary association
was observed for processed meat and total prostate cancer,
although not for advanced or fatal prostate cancer. There
was no evidence of a dose-response relationship between
processed meat and total prostate cancer in meta-
regression or stratified intake analyses; however, future
studies with more detailed intake data would facilitate a
more comprehensive evaluation of any possible dose-
response patterns, particularly by prostate cancer sub-
types, such as high-grade tumors. In addition, we did not
observe any significantly elevated associations in the meta-
analyses of cooking methods, heterocyclic amines, and
total and advanced prostate cancer, although we did ob-
serve a weak association between total mutagenic activity
and total prostate cancer, based on limited data.
Heterocyclic amines and methods of cooking meat at a
high temperature or until well-done have often been sug-
gested as risk factors for prostate cancer. However, the re-
sults of these meta-analyses do not support that
hypothesis. Based on the findings from this meta-analysis,
and given the relatively large volume of prospective cohort
studies, red meat or processed meat intake do not appear
to be associated with increasing the risk of prostate cancer.
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